Augmentin 875 mg/125 mg

Augmentin is a widely recognized broad-spectrum antibiotic containing amoxicillin and clavulanic acid. Developed by Beecham (now part of GSK) in the 1970s, it is one of the most successful pharmaceutical products in history. The brand belongs to the British multinational GSK plc (formerly GlaxoSmithKline), which was formed by the merger of Glaxo Wellcome and SmithKline Beecham in 2000.

While the brand originated in the United Kingdom, its manufacturing is a global operation. Key production sites for Augmentin and its active ingredients (like potassium clavulanate) are located in Worthing (England), Irvine (Scotland), and Mayenne (France). Depending on the specific market and batch, products sold in Europe—including Italy, as seen on the packaging—are typically manufactured in France or the UK. Notably, the rights to the Augmentin brand in the United States were sold to Dr. Reddy's Laboratories in 2010, though GSK retains ownership and manufacturing for the rest of the global market.